Re-evaluation of the big blue® mouse assay of propiconazole suggests lack of mutagenicity

Environmental and Molecular Mutagenesis

Volumn 53, Issue 1, 2012, Pages 1-9

  Shane, Barbara S ^a   Zeiger, Errol ^b   Piegorsch, Walter W ^c   Booth, Ewan D ^d   Goodman, Jay I ^e   Peffer, Richard C ^f  

^a Barbara Shane Consulting   (United States)

^b Errol Zeiger Consulting   (United States)

^c UNIVERSITY OF ARIZONA   (United States)

^d JEALOTT S HILL INTERNATIONAL RESEARCH CENTRE   (United Kingdom)

^e MICHIGAN STATE UNIVERSITY   (United States)

^f SYNGENTA CROP PROTECTION   (United States)

Author keywords

In vivo mutation; Mutation spectrum; Propiconazole; Statistical analysis; Transgenic

Indexed keywords

MYCLOBUTANIL; PROPICONAZOLE;

BACILLUS SUBTILIS; BODY WEIGHT; BONE MARROW; CELL TRANSFORMATION; CHINESE HAMSTER; CHROMOSOME ABERRATION; DNA DAMAGE; DNA REPAIR; GENE MUTATION; GENOTOXICITY; HUMAN; IN VITRO STUDY; IN VIVO STUDY; LIVER CELL; LIVER NECROSIS; LYMPHOMA CELL; MUTAGENICITY; NONHUMAN; NOTE; POINT MUTATION; SACCHAROMYCES CEREVISIAE; SALMONELLA; WEIGHT GAIN;

ANIMALS; LIVER; MALE; MICE; MICE, TRANSGENIC; MUTAGENICITY TESTS; MUTAGENS; MUTATION; TRIAZOLES;

MUS MUSCULUS;

EID: 84855428054     PISSN: 08936692     EISSN: 10982280     Source Type: Journal    
DOI: 10.1002/em.20689     Document Type: Note

References (43)

1. Adams WT, Skopek TR. 1987. Statistical test for the comparison of samples from mutational spectra. J Mol Biol 194: 391-396.
2. Allen JW, Wolf DC, George MH, Hester SD, Sun G, Thai S-F, Delker DA, Moore T, Jones C, Nelson G, Roop BC, Leavitt S, Winkfield E, Ward WO, Nesnow S. 2006. Toxicity profiles in mice treated with hepatotumorigenic and non-hepatotumorigenic triazole conazole fungicides: propiconazole, triadimefon, and myclobutanil. Toxicol Pathol 34: 853-862.
3. Bruno M, Moore T, Nesnow S, Ge Y. 2009. Protein carbonyl formation in response to propiconazole-induced oxidative stress. J Proteome Res, 8: 2070-2078.
4. Bodell WJ, Gaikwad NW, Miller D, Berger MS. 2003. Formation of DNA adducts and induction of lacI mutations in Big Blue Rat 2 cells treated with temozolimide: implications for treatment of low grade adult and pediatric brain tumors. Cancer Epidem Biomarkers Prev 12: 545-551.
5. Chen JX, Zheng Y, West M, Tang M-S. 1999. Carcinogens preferentially bind at methylated CpG in the p53 mutations hotspots. Cancer Res 58: 2070-2075.
6. Cohen SM, Ellwein LB. 1990. Cell proliferation and carcinogenesis. Science 249: 1007-1011.
7. EPA 2003. Propiconazole-2nd Report of the Hazard Identification Assessment Review Committee. US Environmental Protection Agency, TXR No. 0051703. March 26, 2003.
8. EPA 2005. Guidelines for Carcinogen Risk Assessment EPA/630/P-03/001F March 2005.
9. EPA 2006. Propiconazole: Phase 4, HED Chapter of the Re-registration Eligibility Decision Document RED. US Environmental Protection Agency PC Code 122101. June 28, 2006.
10. EPA 2007. Framework for Determining a Mutagenic Mode of Action for Carcinogenicity: Using EPA's 2005 Cancer Guidelines and Supplemental Guidance for Assessing Susceptibility from Early-Life Exposure to Carcinogens EPA 120/R-07/002-A External Peer Review. Draft September 2007.
11. EPA 2011. OCSPP Harmonized Test Guidelines. Series 870-Health Effects Test Guidelines. [see, e.g., TG no. 870.5300; 870.5385; 870.5395]. Available at Accessed Mar. 25, 2011.
12. Farabaugh PJ. 1978. Sequence of the lacI gene. Nature 274: 765-769.
13. Heddle JA, Dean S, Nohmi T, Boerrigter M, Casciano D, Douglas GR, Glickman BW, Gorelick NJ, Mirsalis JC, Martus H-J, Skopek TR, Thybaud V, Tindall KR, Yajima N. 2000. In vivo transgenic mutation assays. Environ Mol Mutagen 35: 253-225.
14. Holsapple MP, Pitot HC, Cohen SH, Boobis AR, Klaunig JE, Pastoor TL, Dellarco VL, Dragan YP. 2006. Mode of action in relevance of rodent liver tumors to human cancer risk. Tox Sci 89: 51-56.
15. INCHEM 1987 Monograph 768 Propiconazole Pesticide Residues in Food: 1987 Evaluations Part II Toxicology. International Programme on Chemical Safety, World Health Organization, Geneva, Switzerland. Available at Accessed 27 January 2011.
16. 6. Environ Mol Mutagen 38: 357-360.
17. Klaunig JE, Kamendulis LM, Hocevar BA. 2010. Oxidative stress and oxidative damage in carcinogenesis. Toxicol Pathol 38: 96-109.
18. Lambert IB, Singer TM, Boucher SE, Douglas GR. 2005. Detailed review of transgenic rodent mutation assays. Mutat Res 590: 1-280.
19. 6 is dependent on both the chirality of the lesion and the local sequence context. J Biol Chem 268: 23427-23434.
20. Leavitt SA, DeAngelo AB, George MH, Ross JA. 1997. Assessment of the mutagenicity of dichloroacetic acid in lacI transgenic B6C3F1 mouse liver. Carcinogenesis 18: 2101-2106.
21. Monroe JJ, Manjanatha MG, Skopek TR. 2001. Extent of CpG methylation is not proportional to the in vivo spontaneous mutation frequency at transgenic loci in Big Blue® rodents. Mutat Res 476: 1-11.
22. Moriya M, Spiegel S, Fernandes A, Amin S, Liu T, Geacintov N, Grollman AP. 1996. Fidelity of translesional synthesis past benzo[a]pyrene diol epoxide-2′-deoxyguanosine DNA adducts: Marked effects of host cell sequence context and chirality. Biochemistry 35: 16646-16651.
23. Nesnow S, Padgett WT, Moore T. 2011. Propiconazole induces alterations in the hepatic metabolome of mice: relevance to propiconazole-induced hepatocarcinogenesis. Toxicol Sci 120: 297-309.
24. Organisation for Economic Co-Operation and Development (OECD). 2011. OECD Guideline For The Testing Of Chemicals. 488: Transgenic Rodent Somatic and Germ Cell Gene Mutation Assays. Paris: Organisation For Economic Co-Operation and Development. Adopted 28 July 2011.
25. Piegorsch WW, Bailer AJ. 1994. Statistical approaches for analyzing mutational spectra: Some recommendations for categorical data. Genetics 136: 403-416.
26. Piegorsch WW, Bailer AJ. 1997. Statistics for Environmental Biology and Toxicology. Boca Raton, FL: Chapman & Hall/CRC Press.
27. Piegorsch WW, Bailer AJ. 2005. Analyzing Environmental Data. Chichester: John Wiley & Sons.
28. R Development Core Team. 2011. R: A Language and Environment for Statistical Computing. Vienna, Austria: R Foundation for Statistical Computing.
29. Robins H, Press WH. 2005. Human microRNAs target a functionally distinct population of genes with AT-rich 3′ UTRs. Proc Natl Acad Sci USA 102: 15557-15562.
30. Ross JA, Leavitt SA. 1998. Induction of mutations by 2-acetyl-aminofluorene in lacl transgenic B6C3F1 mouse liver. Mutagenesis 13: 173-179.
31. Ross JA, Leavitt SA. 2010. Analysis of the mutations induced by conazole fungicides in vivo. Mutagenesis 25: 231-234.
32. Ross JA, Moore T, Leavitt SA. 2009. In vivo mutation of conazole fungicides correlates with tumorigenicity. Mutagenesis 24: 149-152.
33. Shane BS, deBoer J, Watson DE, Haseman JK, Glickman BJ, Tindall KR. 2000. LacI mutation spectrum following benzo(a)pyrene treatment of Big Blue® mice. Carcinogenesis 21: 715-725.
34. Shane BS, Lockhart A-MC, Winston GW, Tindall KR. 1997. Mutant frequency of lacI in transgenic mice following benzo(a)pyrene treatment and partial hepatectomy. Mutat Res 377: 1-11.
35. Shen, J-C, Rideout WMIII, Jones PA. 1994. The rate of hydrolytic deamination of 5-methylcytosine in double-stranded DNA. Nucleic Acids Res 22: 972-976.
36. Slikker W, Mei N, Chen T. 2004. N-Ethyl-N-nitrosourea (ENU) increased brain mutations in prenatal and neonatal mice but not in the adults. Tox Sci 81: 112-120.
37. Tarone RE. 1979. Testing the goodness of fit of the binomial distribution. Biometrika 66: 585-590.
38. Thybaud V, Dean S, Nohmi T, de Boer J, Douglas GR, Glickman BW, Gorelick NJ, Heddle JA, Heflich RH, Lambert I, Martus HJ, Mirsalis JC, Suzuki T, Yajima N. 2003. In vivo transgenic mutation assays. Mutat Res 540: 141-151.
39. Versteeg R, van Schaik BDC, van Batenburg MF, Roos M, Monajemi R, Caron H, Bussemaker HJ, van Kampen AHC. 2003. The human transcriptome map reveals extremes in gene density, intron length, GC content, and repeat pattern for domains of highly and weakly expressed genes. Genome Res 13: 1998-2004.
40. WHO 2006 Propiconazole. In: Pesticide Residues in Food - 2004 Joint FAO/WHO Meeting on Pesticide Residues. Part II-Toxicological. World Health Organization. Geneva, Switzerland WHO/PCS/061. pp. 281-324.
41. Yoon J-H, Smith LE, Feng Z, Tang M-S, Lee C-S, Pfeifer GP. 2001. Methylated CpG dinucleotiudes are preferential targets for G to T transversion mutations induced by benzoapyrene diol epoxide in mammalian cells: similarities with p53 mutation spectrum in smoking-associated lung cancers. Cancer Res 61: 7110-7177.
42. You YH, Halangoda A, Buettner V, Hill K, Sommer S, Pfeifer G. 1998. Methylation of CpG dinucleotides in the lacI gene of the Big Blue® transgenic mouse. Mutat Res 420 55-65.
43. Zhang S, Glickman BW, de Boer JG. 2001. Spontaneous mutation of the lacI transgene in rodents: Absence of species, strain, and insertion-site influence. Environ Mol Mutagen 37: 141-146.